HK1253854A1 - 抗微生物融合肽 - Google Patents
抗微生物融合肽Info
- Publication number
- HK1253854A1 HK1253854A1 HK18112987.0A HK18112987A HK1253854A1 HK 1253854 A1 HK1253854 A1 HK 1253854A1 HK 18112987 A HK18112987 A HK 18112987A HK 1253854 A1 HK1253854 A1 HK 1253854A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- fusion peptides
- antimicrobial fusion
- antimicrobial
- peptides
- fusion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562171868P | 2015-06-05 | 2015-06-05 | |
PCT/US2016/035896 WO2016197049A1 (en) | 2015-06-05 | 2016-06-03 | Antimicrobial fusion peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1253854A1 true HK1253854A1 (zh) | 2019-07-05 |
Family
ID=57442002
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18112987.0A HK1253854A1 (zh) | 2015-06-05 | 2018-10-11 | 抗微生物融合肽 |
Country Status (5)
Country | Link |
---|---|
US (4) | US10543250B2 (zh) |
EP (1) | EP3302515A4 (zh) |
CN (1) | CN108367042B (zh) |
HK (1) | HK1253854A1 (zh) |
WO (1) | WO2016197049A1 (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200165309A1 (en) * | 2017-05-11 | 2020-05-28 | Los Angeles Biomedical Research Institute at Flarbor-UCLA Medical Center | Antimicrobial peptides with alpha-core helices |
CN110305890A (zh) * | 2019-07-02 | 2019-10-08 | 河南城建学院 | 一种新型5种抗菌肽串联表达重组工程菌构建方法及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7820619B1 (en) * | 1998-02-18 | 2010-10-26 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Antimicrobial peptides and derived metapeptides |
US20100144641A1 (en) * | 2005-09-12 | 2010-06-10 | Popel Aleksander S | Compositions Having Antiangiogenic Activity and Uses Thereof |
US20100113342A1 (en) * | 2006-06-20 | 2010-05-06 | Yount Nannette I | Antimicrobial kinocidin compositions and methods of use |
WO2008006125A1 (en) * | 2006-07-10 | 2008-01-17 | Österreichische Akademie der Wissenschaften | Antimicrobial peptides |
AU2007292221B2 (en) | 2006-09-06 | 2013-08-29 | The Regents Of The University Of California | Selectively targeted antimicrobial peptides and the use thereof |
US20140296137A1 (en) * | 2013-04-01 | 2014-10-02 | Los Alamos National Security, Llc | Methods and compositions for controlling rotifers |
US20200165309A1 (en) * | 2017-05-11 | 2020-05-28 | Los Angeles Biomedical Research Institute at Flarbor-UCLA Medical Center | Antimicrobial peptides with alpha-core helices |
-
2016
- 2016-06-03 EP EP16804596.1A patent/EP3302515A4/en active Pending
- 2016-06-03 WO PCT/US2016/035896 patent/WO2016197049A1/en active Application Filing
- 2016-06-03 CN CN201680045681.0A patent/CN108367042B/zh active Active
- 2016-06-03 US US15/579,926 patent/US10543250B2/en active Active
-
2018
- 2018-10-11 HK HK18112987.0A patent/HK1253854A1/zh unknown
-
2020
- 2020-01-15 US US16/743,455 patent/US20200138900A1/en not_active Abandoned
-
2021
- 2021-06-24 US US17/357,784 patent/US20220054584A1/en not_active Abandoned
-
2023
- 2023-08-22 US US18/453,936 patent/US20240156899A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3302515A4 (en) | 2018-12-26 |
CN108367042B (zh) | 2022-03-01 |
US20180221439A1 (en) | 2018-08-09 |
EP3302515A1 (en) | 2018-04-11 |
US20200138900A1 (en) | 2020-05-07 |
US10543250B2 (en) | 2020-01-28 |
WO2016197049A1 (en) | 2016-12-08 |
US20220054584A1 (en) | 2022-02-24 |
US20240156899A1 (en) | 2024-05-16 |
CN108367042A (zh) | 2018-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201509413D0 (en) | Fusion protein | |
GB201520559D0 (en) | Peptides | |
GB201504691D0 (en) | Fusion protein | |
GB201520536D0 (en) | Peptides | |
HK1257937A1 (zh) | 融合蛋白 | |
GB201520546D0 (en) | Peptides | |
GB201520545D0 (en) | Peptides | |
GB201520563D0 (en) | Peptides | |
HK1253854A1 (zh) | 抗微生物融合肽 | |
GB201520562D0 (en) | Peptides | |
GB201520550D0 (en) | Peptides | |
GB201520544D0 (en) | Peptides | |
GB201520567D0 (en) | Peptides | |
GB201520543D0 (en) | Peptides | |
GB201520541D0 (en) | Peptides | |
GB201520539D0 (en) | Peptides | |
GB201405891D0 (en) | Modified antimicrobial peptides | |
GB201520548D0 (en) | Peptides | |
GB201520568D0 (en) | Peptides | |
GB201520570D0 (en) | Peptides | |
GB201520566D0 (en) | Peptides | |
GB201520542D0 (en) | Peptides | |
GB201520564D0 (en) | Peptides | |
GB201520557D0 (en) | Peptides | |
GB201520558D0 (en) | Peptides |